Merck KGaA (ETR:MRK)
Germany
· Delayed Price · Currency is EUR | Market Cap | 46.35B |
| Revenue (ttm) | 21.22B |
| Net Income (ttm) | 2.86B |
| Shares Out | 434.78M |
| EPS (ttm) | 6.59 |
| PE Ratio | 16.18 |
| Forward PE | 12.34 |
| Dividend | 2.20 (2.06%) |
| Ex-Dividend Date | Apr 28, 2025 |
| Volume | 216,332 |
| Average Volume | 266,214 |
| Open | 105.50 |
| Previous Close | 106.20 |
| Day's Range | 105.05 - 107.05 |
| 52-Week Range | 100.70 - 168.25 |
| Beta | 0.61 |
| RSI | 43.62 |
| Earnings Date | Nov 13, 2025 |
About Merck KGaA
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment also provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and test... [Read more]
Financial Performance
In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. Earnings were 2.78 billion, a decrease of -1.66%.
Financial StatementsNews
Senator Rasha Kelej Received Senegal First Lady at the 7th Edition of Merck Foundation First Ladies Initiative Summit to Discuss the Impact of Their Joint Programs to Build Healthcare Capacity and Address Social and Health Issues
Business Wire India Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit 2025 recently. It was inaugurate...
Chinese police investigating app fraud case, says German drugmaker Merck KGaA
Police in China are investigating an app fraud case, said German healthcare firm Merck KGaA , amid growing concerns over entities claiming affiliation with major corporations.
Merck and Siemens Deepen Strategic Partnership to Accelerate AI and Data-Driven Drug Discovery and Development
DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, and Siemens, a leading technology company, signed a new Memorandum of Understanding (MoU), extending their strateg...
Senator Dr. Rasha Kelej Welcomes Nigeria First Lady at the 7th Edition of Their First Ladies Initiative Summit to Discuss Their Joint Programs to Build Healthcare Capacity, Break Infertility Stigma and Support Girl Education
Business Wire India Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit 2025 recently. It was inaugurate...
Merck Foundation CEO and Mozambique First Lady Sign MoU to Underscore Their Long-Term Partnership to Strengthen Healthcare Capacity During the Merck Foundation First Ladies Initiative Summit 2025
Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit 2025 recently. Business Wire India Merck Foundation,...
Senator Rasha Kelej Received Maldives First Lady at the 7th Edition of Merck Foundation First Ladies Initiative Summit to Discuss Their Joint Programs to Build Healthcare Capacity
Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit 2025 recently. Business Wire India Merck Foundation,...
Senator Rasha Kelej Received Kenya First Lady at the 7th Edition of Merck Foundation First Ladies Initiative Summit to Discuss Their Joint Programs to Build Healthcare Capacity
Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit 2025 recently. Business Wire India Merck Foundation,...
Merck Foundation CEO, Dr. Rasha Kelej Welcomed First Lady of Central African Republic at the 7th Edition of Merck Foundation First Ladies Initiative 2025
Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit 2025 recently. Business Wire India Merck Foundation,...
Merck Foundation CEO Meets the First Lady of Cabo Verde & 13 African and Asian First Ladies of Africa at the Merck Foundation First Ladies Initiative Summit 2025
Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit 2025 recently. It was inaugurated by Prof. Dr. Frank...
Merck Foundation CEO Meets Zimbabwe First Lady & 13 First Ladies of Africa and Asia at the 7th Edition of Merck Foundation First Ladies Initiative Summit to Discuss the Strategy to Build Healthcare Capacity and Support Girl Education
Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit 2025 recently. Business Wire India Merck Foundation,...
Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions
BEIJING — Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovativ...
Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions
BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drug...
Merck KGaA, Darmstadt, Germany, Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector
DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the appointment of David Weinreich, MD, MBA, as Global Head of R&D and Ch...
mRNA Biotechs - Long-Term Value Risks Abound
mRNA vaccine companies are overhyped post-pandemic, facing scientific, operational, and regulatory headwinds that limit long-term investment appeal. Scientific and business risks, including delivery c...
European Commission Grants Approval of OGSIVEO (nirogacestat) for the Treatment of Adults with Desmoid Tumors
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors STAMFORD, Conn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc....
Merck KGaA 2025 Q2 - Results - Earnings Call Presentation
Merck KGaA (MKGAF) Q2 2025 Earnings Call Transcript
Merck KGaA gives Q2 results
Merck Foundation CEO and First Ladies of Africa to Call for Action to Build Healthcare and Media Capacity, Break Infertility Stigma and Support Girl Education in 2026 and Beyond
Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit 2025 on 19th and 20th June. Business Wire India Merc...
Merck Foundation Provides Training for Journalists from 35 Countries During the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit
Business Wire India Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit 2025, in presence of Merck Found...
Merck Foundation Together with African and Asian First Ladies Mark ‘World Assisted Reproductive Technology Day’ 2025 Through Their ‘More Than a Mother’ Campaign
Merck Foundation, the philanthropic arm of Merck KGaA Germany, marks ‘World ART (Assisted Reproductive Technology) Day 2025′ together with African and Asian First Ladies, who are also the Ambassadors ...
Merck KGaA: The Undervaluation Is Now Close To 13-Year Lows
MilliporeSigma and Washington University in St. Louis Sign MoU to Advance Scientific Collaboration
Strengthens 90-year legacy of partnership between MilliporeSigma and WashU to accelerate scientific progress Strategic academic-industry alliance aims to build robust Research & Development talent pip...
Merck KGaA gets EU nod for Ezmekly
European Commission Grants Conditional Approval of EZMEKLY (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms – STAMFORD,...